Community-associated methicillin resistant Staphylococcus aureus infection
| Year |
Number1 |
Mid-year population2 |
Cases / 100,000 population |
Number (%) resistant to mupirocin |
| 2007 |
173 |
6,916,300 |
2.5 |
Data not available |
| 2008 |
282 |
6,957,800 |
4.1 |
Data not available |
| 2009 |
368 |
6,972,800 |
5.3 |
Data not available |
| 2010 |
495 |
7,024,200 |
7.0 |
Data not available |
| 2011 |
624 |
7,071,600 |
8.8 |
Data not available |
| 2012 |
815 |
7,150,100 |
11.4 |
Data not available |
| 2013 |
990 |
7,178,900 |
13.8 |
Data not available |
| 2014 |
997 |
7,229,500 |
13.8 |
6 (0.60) |
| 2015 |
1,046 |
7,291,300 |
14.3 |
6 (0.57) |
| 2016 |
1,167 |
7,336,600 |
15.9 |
4 (0.34) |
| 2017 |
1,258 |
7,393,200 |
17.0 |
5 (0.40) |
| 2018 |
1,218 |
7,452,600 |
16.3 |
7 (0.57) |
| 2019 |
1,236 |
7,507,900 |
16.5 |
4 (0.32) |
| 2020 |
813 |
7,481,000 |
10.9 |
7 (0.86) |
| 2021 |
582 |
7,413,100 |
7.9 |
1 (0.17) |
| 2022 |
416 |
7,346,100 |
5.7 |
3 (0.72) |
| 2023 |
469 |
7,536,100 |
6.2 |
4 (0.85) |
| 2024 |
576 |
7,524,100 |
7.7 |
4 (0.69) |
| 2025 |
427 |
7,498,900 |
5.7 |
4 (0.94) |
| Antimicrobial |
Year |
| 2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Clindamycin |
Cases tested |
774 |
536 |
422 |
301 |
351 |
436 |
316 |
| % Susceptible |
66.9 |
68.3 |
67.8 |
71.4 |
68.4 |
62.4 |
64.9 |
| % Resistant |
33.1 |
31.5 |
32.0 |
28.6 |
31.3 |
37.4 |
34.8 |
| Erythromycin |
Cases tested |
852 |
571 |
533 |
381 |
429 |
537 |
402 |
| % Susceptible |
47.8 |
52.7 |
52.9 |
57.0 |
51.0 |
48.0 |
49.0 |
| % Resistant |
48.2 |
45.2 |
43.5 |
40.9 |
47.1 |
49.2 |
49.0 |
| Doxycycline |
Cases tested |
212 |
129 |
90 |
91 |
64 |
120 |
113 |
| % Susceptible |
87.3 |
85.3 |
91.1 |
89.0 |
85.9 |
87.5 |
76.1 |
| % Resistant |
3.3 |
3.1 |
1.1 |
7.7 |
4.7 |
4.2 |
8.0 |
| Minocycline |
Cases tested |
129 |
88 |
74 |
88 |
63 |
96 |
74 |
| % Susceptible |
100.0 |
100.0 |
100.0 |
90.9 |
96.8 |
92.7 |
95.9 |
| % Resistant |
0.0 |
0.0 |
0.0 |
8.0 |
3.2 |
7.3 |
4.1 |
| Gentamicin |
Cases tested |
788 |
500 |
453 |
326 |
371 |
458 |
340 |
| % Susceptible |
90.2 |
88.2 |
90.9 |
89.6 |
86.5 |
90.8 |
93.8 |
| % Resistant |
8.1 |
10.0 |
6.8 |
8.6 |
12.1 |
7.6 |
5.0 |
| Co-trimoxazole |
Cases tested |
981 |
622 |
458 |
328 |
384 |
461 |
348 |
| % Susceptible |
97.3 |
97.6 |
97.4 |
97.3 |
98.7 |
97.4 |
98.6 |
| % Resistant |
2.4 |
1.8 |
2.2 |
2.4 |
1.3 |
2.4 |
1.4 |
| Total cases notified in year |
1,236 |
813 |
582 |
416 |
469 |
576 |
427 |